Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kendle | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Kendle

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Martha R. Feller, Ph.D., has been promoted to senior vice president, global clinical development, Kendle. Also, Ubavka M. Denoble, M.D. and Judith H. Swilley, Ph.D., have been appointed vice president and senior director, global clinical development, North America, respectively. These appointments are part of an effort to strengthen the company’s global clinical development leadership team to drive continued growth in its Phase II-III business worldwide.

Dr. Feller will provide executive leadership for the company’s Phase II-III operations in North America, Europe, Asia/Pacific, Latin America and Africa. Dr. Denoble and Dr. Swilley will provide strategic oversight and direction for the company’s Phase II-III clinical development activities in North America, where each will be responsible for specialized therapeutic and dedicated customer account teams in this region. Dr. Denoble and Dr. Swilley will report to Dr. Feller.

Dr. Feller has nearly 30 years of CRO and pharmaceutical industry experience. She most recently served as senior vice president, global clinical development, North America, a position she has held since joining the company in 2004 from Procter & Gamble Pharmaceuticals. She has expertise in all phases of drug development for both prescription and OTC products across multiple therapeutic areas.

Dr. Denoble has served as vice president, global safety and pharmacovigilance, since joining the company in 2006 as part of the Charles River Clinical Services acquisition. In this role, she has provided strategic leadership for the global safety function. She has more than 20 years of CRO and clinical experience, including executive roles in medical affairs, safety/pharmacovigilance and clinical development. She has expertise in ophthalmology and cardiovascular therapeutic areas.

Dr. Swilley has served as a senior director, global clinical development, North America since joining the company in 2006 as part of the Charles River Clinical Services acquisition. In this role, she provides leadership for Phase II-III projects worldwide. Dr. Swilley has more than 20 years of clinical and training experience in the CRO and pharmaceutical industries, including senior positions in clinical monitoring and staff training and development. She has expertise in oncology, infectious disease and dermatology therapeutic areas.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics